The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H.
Nalini S Bora; Sankaranarayanan Kaliappan; Purushottam Jha; Qin Xu; Jeong-Hyeon Sohn; Dhara B Dhaulakhandi; Henry J Kaplan; Puran S Bora (Profiled Author: Jeong-Hyeon Sohn)
Department of Ophthalmology, Jones Eye Institute, Pat and Willard Walker Eye Research Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. email@example.com
Journal of immunology (Baltimore, Md. : 1950) 2006;177(3):1872-8.
The objective of this study was to explore the role of classical, lectin, and alternative pathways of complement activation in laser-induced choroidal neovascularization (CNV). The classical and alternative pathways were blocked in C57BL/6 mice by small interfering RNAs (siRNA) directed against C1q and factor B, respectively. C4(-/-) mice developed CNV similar to their wild-type controls and inhibition of C1q by siRNA had no effect on the development of CNV. In contrast, CNV was significantly inhibited (p < 0.001) in C5(-/-) mice and C57BL/6 mice treated with factor B siRNA. Inhibition of the alternative pathway by factor B siRNA resulted in decreased levels of membrane attack complex and angiogenic factors-vascular endothelial growth factor and TGF-beta2. Furthermore, factor B was up-regulated in complement sufficient C57BL/6 mice at day 1 postlaser and remained elevated at day 7. Significantly reduced levels of factor H were observed at day 3 in these animals. In conclusion, our results demonstrate that activation of the factor B-dependent alternative pathway, but not the classical or lectin pathways, was essential for the development of CNV in mouse model of laser-induced CNV. Thus, specific blockade of the alternative pathway may represent a therapeutically relevant strategy for the inhibition of CNV.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Puran S Bora; Jeong-Hyeon Sohn; Jose M C Cruz; Purushottam Jha; Hiroki Nishihori; Yali Wang; Sankaranarayanan Kaliappan; Henry J Kaplan; Nalini S BoraJournal of immunology (Baltimore, Md. : 1950) 2005;174(1):491-7.
Kelly C Nelson; Minglang Zhao; Pamela R Schroeder; Ning Li; Rick A Wetsel; Luis A Diaz; Zhi LiuThe Journal of clinical investigation 2006;116(11):2892-900.
K Kitisin; N Ganesan; Y Tang; W Jogunoori; E A Volpe; S S Kim; V Katuri; B Kallakury; M Pishvaian; C Albanese; et al.Oncogene 2007;26(50):7103-10.
Appears in this Publication
Author of this Publication